Suan Lee - Haw Par Insider

HAWPY -- USA Stock  

USD 35.24  0.00  0.00%

Non-Executive Independent Director

Dr. Lee Suan Yew is NonExecutive Independent Director of Haw Par Corporationrationration Ltd. He is a medical practitioner with over 50 years experience. He was appointed to the Board on 18 December 1995 and was last reappointed on 29 April 2016. He is a member of the Nominating Committee. Dr Lee is a Director of K1 Ventures Limited. He was appointed Justice of the Peace from 1998 2008. Dr Lee was President of the Singapore Medical Council for 4 years and was also Chairman of the Singapore National Medical Ethics Committee . For his numerous public services, he was awarded the Public Service Star in 1991 and Public Service Star in 2002. He holds a M.B.B. Chir. degree from the University of Cambridge and MRCP and FRCP from the Royal College of Physicians, Glasgow.
Age: 82  Director Since 1995  Ph.D    
65 6337 9102  http://www.hawpar.com

Management Efficiency

The company has return on total asset (ROA) of 1.57 % which means that it generated profit of $1.57 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 4.4 % meaning that it generated $4.4 on every $100 dollars invested by stockholders.
The company has accumulated 34.27 M in total debt with debt to equity ratio (D/E) of 1.3 which is about average as compared to similar companies. Haw Par Corporation Limited has Current Ratio of 8.27 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in pharmaceutical and healthcare products. The company was incorporated in 1969 and is based in Singapore. Haw Par is traded on OTC Market in USA.Haw Par Corporation Limited (HAWPY) is traded on OTC Market in USA. It is located in No. 03-03 Haw Par Technocentre and employs 546 people.

Haw Par Limited Leadership Team

Sat Khattar, Director
Siew Shiu, Executive
Meng Kwek, Executive
Anthony Chang, Executive
Swee Sim, Director
Cho Wee, Chairman, Ph.D
Suan Lee, Director, Ph.D
Chua Keeth, Executive
Wah Ng, Executive
Ah Han, Director
Hiang Gn, Director
Seok Lim, CFO, MBA
Ee Wee, CEO
Sien Tarn, Executive, MBA
Mui Kow, Executive
Sung Whang, Executive
Soo Hwang, Director
Bee Goh, Director
Eechao Wee, Director
Peter Chew, Executive
Kia Chew, Director, CPA
Jasmin Hong, Executive

Stock Performance Indicators

Did you try this?

Run Portfolio Backtesting Now
   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Portfolio Backtesting

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.